World Journal of Surgical Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2021-09-18 146e0980m70暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审...

90 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2021-07-21 ms7000000941789537

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;基础
经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵

81 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-05-10 ms4000000895536260

偏重的研究方向：乳腺癌
经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？

55 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2020-08-18 無道太上

审稿速度:1.0 | 投稿命中率:75.0
经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还#肿瘤#算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。

699 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-05-30 ms4000000895536260

一直是1 reviewer report recieved。何时是个头？

59 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-01-15 1232295cm61暂无昵称

审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0
偏重的研究方向：肿瘤
经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，

79 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-05-21 zhuzhu19861

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了

54 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-09-13 xuanzixue02

我的邀请了70个审稿人

50 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-03-14 ms7000000119203040

大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧

77 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052815, encodeId=72dc105281543, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：整整10个审稿人，我这文章何德何能用得着这么多人来审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Sat Sep 18 15:33:54 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001527, encodeId=4a7f100152e52, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;基础 经验分享：投稿方向为生信分析加基础验证，现在已经接收收。一审差不多一个半月，然后小修了几次，差不多一周就可以修回。审稿人偏多，意见都比较中肯。投稿到接收差不多四个半月，其中一个月补实验，另一月自己有事耽搁了。但总的来说还是比较好投，时间较快。审稿费偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d9f5458882, createdName=ms7000000941789537, createdTime=Wed Jul 21 22:38:44 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218384, encodeId=52d71218384a0, content=偏重的研究方向：乳腺癌 经验分享：十天了一直是Reviewer(s) invited，不知道何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Tue May 10 09:59:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809992, encodeId=2c58809992be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一篇预后相关meta，六月一号第一次投稿，第三天送外审，一审到六月底，两个审稿人，外审意见文章都有解释，但编辑拒稿，表明如果解决问题可以重投，完善文章，回复审稿人意见，七月初再投，第二天外审，七月底外审结束，审稿人1提了几个小问题，审稿人2一个小问题，审稿人3没有问题，编辑给了大修，8月4号修回，8月7号再次外审，8月8号外审结束（一脸懵，后来发现是编辑重新发给了审稿人2，秒同意接收），煎熬一周后8月15接收。还<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>算幸运，总体来说编辑处理稿件迅速，审稿人友好，就是版面费有点贵17000+。着急毕业没有分数要求的可以尝试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=699, replyNumber=15, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/29/b36f145a7d39b1f9ada766a714a401ff.jpg, createdBy=2a9d5145284, createdName=無道太上, createdTime=Tue Aug 18 09:54:19 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184633, encodeId=40a611846333b, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2600.0 偏重的研究方向：肿瘤 经验分享：先投了一次，大修拒了，修回后小修接收。处理得很快。初投的可以尝试，问问大佬们，接收了多久交钱呀，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=545f2385974, createdName=1232295cm61暂无昵称, createdTime=Sat Jan 15 19:14:23 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221397, encodeId=e52a122139e1b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：proof是交完版面费之后填还是之前我投稿用的是老板的邮箱担心杂志把通讯当成第一作者了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04735498057, createdName=zhuzhu19861, createdTime=Sat May 21 14:36:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202377, encodeId=b08c12023e77d, content=大修后返稿已经马上两周了，还是under review，二审抓紧给个意见吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5745550350, createdName=ms7000000119203040, createdTime=Mon Mar 14 08:17:58 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217746, encodeId=20ce121e746e4, content=一直处于Quality check in progress ，是什么情况呀？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99298116595, createdName=ms5000000202400576, createdTime=Sun May 08 00:34:00 CST 2022, time=2022-05-08, status=1, ipAttribution=)]

2022-05-08 ms5000000202400576

一直处于Quality check in progress ，是什么情况呀？

175 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务